Bergman, Correa Lead Letter Urging FDA to Expedite Review of Breakthrough Mental Health Therapies
Caucus, led 30 bipartisan colleagues in sending a letter to Food and Drug Administration (FDA) Commissioner Martin … individuals, families, and communities across the country. The letter follows President Trump’s April 18 signing